1075781

Seaway Pharma Inc. — FEI 3012275336

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
December 10, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Massena, NY (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
115921 CFR 211.28(a)Clothing appropriate for duties performed
122021 CFR 211.67(b)(3)Cleaning SOPs/instructions
163621 CFR 211.130(e)Packaging line inspection before use
188321 CFR 211.165(a)Testing and release for distribution
188621 CFR 211.165(c)Sampling and testing plans not described
189021 CFR 211.165(e)Test methods
191221 CFR 211.166(a)Written program not followed
240121 CFR 211.194(a)(4)Complete Test Data
344521 CFR 211.65(a)Equipment construction - reactive surfaces
354721 CFR 211.46(b)Equipment for Environmental Control
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
356521 CFR 211.58Buildings not maintained in good state of repair
435221 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
436921 CFR 211.188(b)(11)Identification of persons involved, each significant step